AccScience Publishing / JCTR / Online First / DOI: 10.36922/JCTR026320084
Submit to JCTR
Cite this article
2
Download
74
Views
Related Info Links
Google Scholar
More by Authors Links
Michael Z. Zulu
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
REVIEW ARTICLE

From decidua to brain: Immune pathways linking maternal infections to neurodevelopmental disorders in offspring

Liesl Strydom1,2 ,  Khethelo R. Xulu1 ,  Michael Z. Zulu2,3*
Show Less
1 School of Molecular & Cell Biology, Faculty of Science, University of the Witwatersrand, Johannesburg , South Africa
2 Division of Virology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg , South Africa
3 Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town , South Africa
JCTR, 026320084 https://doi.org/10.36922/JCTR026320084
Received: 6 August 2026 | Revised: 24 August 2026 | Accepted: 4 September 2026 | Published online: 8 October 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Download PDF
XML
Cite
Abstract

Background: The decidua, a specialised endometrial tissue formed during pregnancy, balances maternal tolerance to the semi-allogeneic fetus with defence against pathogens; maternal infections disrupt this environment, triggering maternal immune activation, placental dysfunction, and adverse fetal neurodevelopment. Aim: To compare how human immunodeficiency virus (HIV), Zika virus, and cytomegalovirus (CMV) dysregulate the decidual microenvironment and how these disruptions contribute to adverse neurodevelopmental outcomes in offspring. Methods: A narrative review of the published literature was conducted, synthesising evidence on pathogen-specific effects on decidual immune regulation, maternal immune activation, placental dysfunction, epigenetic modifications, and neurodevelopmental outcomes. Results: HIV predominantly induces chronic systemic inflammation and placental insufficiency; Zika virus directly infects decidual and placental cells to breach the maternal–fetal barrier; and CMV exerts combined cytopathic and inflammatory effects. Despite distinct mechanisms, all three pathogens disrupt the decidual microenvironment and converge on epigenetic reprogramming as a shared molecular pathway linking prenatal immune challenge to persistent neurodevelopmental impairment. Conclusion: Comparative evaluation of pathogen-specific mechanisms clarifies how maternal infections influence fetal neurodevelopment and highlights shared and divergent targets for future preventive and therapeutic strategies. Relevance for patients: These findings may support earlier prenatal screening, informed clinical management of at-risk pregnancies, and interventions to reduce long-term neurodevelopmental disorders in exposed children.

Keywords
Decidua
Maternal–fetal interface
Human immunodeficiency virus
Zika virus
Cytomegalovirus
Neurodevelopment
Epigenetics
Funding
M.Z.Z. is supported by the South African Medical Research Council (SAMRC) through its Division of Research Capacity Development under the Research Capacity Development Initiative from funding received from the South African National Treasury. The content and findings reported/illustrated are the sole deduction, view and responsibility of the researcher and do not reflect the official position and sentiments of the SAMRC.
Conflict of interest
The authors declare they have no competing interests.
References
  1. Barthes J, Özçelik H, Hindié M, Ndreu-Halili A, Hasan A, Vrana NE. Cell Microenvironment Engineering and Monitoring for Tissue Engineering and Regenerative Medicine: The Recent Advances. BioMed Res Int. 2014;2014:921905. doi: 10.1155/2014/921905
  2. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev. 2009;23(7):781-783. doi: 10.1101/gad.1787609
  3. Meaney MJ. Epigenetics and the Biological Definition of Gene × Environment Interactions. Child Dev. 2010;81(1):41-79. doi: 10.1111/j.1467-8624.2009.01381.x
  4. Erlebacher A. Immunology of the Maternal-Fetal Interface. Annu Rev Immunol. 2013;31(1):387-411. doi: 10.1146/annurev-immunol-032712-100003
  5. Ameer MA, Peterson DC. Anatomy, abdomen and pelvis: uterus. In: StatPearls [Internet]. Treasure Island (FL), USA: StatPearls Publishing; 2026. Accessed September 10, 2026. https://www.ncbi.nlm.nih.gov/books/NBK470297/
  6. Mori M, Bogdan A, Balassa T, Csabai T, Szekeres-Bartho J. The decidua—the maternal bed embracing the embryo—maintains the pregnancy. Semin Immunopathol. 2016;38(6):635-649. doi: 10.1007/s00281-016-0574-0
  7. Liu S, Diao L, Huang C, Li Y, Zeng Y, Kwak-Kim JYH. The role of decidual immune cells on human pregnancy. J Reprod Immunol. 2017;124:44-53. doi: 10.1016/j.jri.2017.10.045
  8. Stope MB, Mustea A, Sänger N, Einenkel R. Immune Cell Functionality during Decidualization and Potential Clinical Application. Life. 2023;13(5):1097. doi: 10.3390/life13051097
  9. Vinketova K, Mourdjeva M, Oreshkova T. Human Decidual Stromal Cells as a Component of the Implantation Niche and a Modulator of Maternal Immunity. J Pregnancy. 2016;2016:1-17. doi: 10.1155/2016/8689436
  10. Lindau R, Vondra S, Spreckels J, et al. Decidual stromal cells support tolerance at the human foetal-maternal interface by inducing regulatory M2 macrophages and regulatory T-cells. J Reprod Immunol. 2021;146:103330. doi: 10.1016/j.jri.2021.103330
  11. Llorca T, Ruiz-Magaña MJ, Abadía AC, Ruiz-Ruiz C, Olivares EG. Decidual stromal cells: fibroblasts specialized in immunoregulation during pregnancy. Trends Immunol. 2025;46(2):138-152. doi: 10.1016/j.it.2024.12.007
  12. Gori S, Soczewski E, Fernández L, et al. Decidualization Process Induces Maternal Monocytes to Tolerogenic IL-10-Producing Dendritic Cells (DC-10). Front Immunol. 2020;11:1571. doi: 10.3389/fimmu.2020.01571
  13. Yang Y, Wang W, Weng J, et al. Advances in the study of HLA class Ib in maternal-fetal immune tolerance. Front Immunol. 2022;13:976289. doi: 10.3389/fimmu.2022.976289
  14. Xu L, Li Y, Sang Y, Li Da J, Du M. Crosstalk Between Trophoblasts and Decidual Immune Cells: The Cornerstone of Maternal-Fetal Immunotolerance. Front Immunol. 2021;12. doi: 10.3389/fimmu.2021.642392
  15. Balasundaram P, Farhana A. Immunology at the maternal-fetal interface. In: StatPearls [Internet]. Treasure Island (FL), USA: StatPearls Publishing; 2026. Accessed September 10, 2026. https://www.ncbi.nlm.nih.gov/books/NBK574542/
  16. Bian Q, Fu B. Immunological microenvironment at the maternal-fetal interface. J Reprod Immunol. 2022;151:103632. doi: 10.1016/j.jri.2022.103632
  17. Borowski S, Tirado-Gonzalez I, Freitag N, Garcia MG, Barrientos G, Blois SM. Altered Glycosylation Contributes to Placental Dysfunction Upon Early Disruption of the NK Cell-DC Dynamics. Front Immunol. 2020;11:1316. doi: 10.3389/fimmu.2020.01316
  18. Faas MM. Uterine natural killer cells and successful pregnancy: from mouse experiments to human physiology. Explor Immunol. 2022;2:518-539. doi: 10.37349/ei.2022.00065
  19. Shynlova O, Boros-Rausch A, Farine T, Adams KM, Dunk C, Lye SJ. Decidual Inflammation Drives Chemokine-Mediated Immune Infiltration Contributing to Term Labor. J Immunol. 2021;207(8):2015-2026. doi: 10.4049/jimmunol.2100493
  20. Jaan A, Rajnik M. TORCH complex. In: StatPearls [Internet]. Treasure Island (FL), USA: StatPearls Publishing; 2026. Accessed September 10, 2026. https://www.ncbi.nlm.nih.gov/books/NBK560528/
  21. Devaraju M, Li A, Ha S, et al. Beyond TORCH: A narrative review of the impact of antenatal and perinatal infections on the risk of disability. Neurosci Biobehav Rev. 2023;153:105390. doi: 10.1016/j.neubiorev.2023.105390
  22. Patel N, Chaudhari K, Patel DJ, Joshi JS, Jyotsna G. TORCH (Toxoplasmosis, Other, Rubella, Cytomegalovirus, Herpes Simplex Virus) Infection and the Enigma of Anomalous Fetal Development: Pregnancy Puzzles. Cureus. 2024;16(1):e51534. doi: 10.7759/cureus.51534
  23. Parker EL, Silverstein RB, Verma S, Mysorekar IU. Viral-Immune Cell Interactions at the Maternal-Fetal Interface in Human Pregnancy. Front Immunol. 2020;11:522047. doi: 10.3389/fimmu.2020.522047
  24. Megli CJ, Coyne CB. Infections at the maternal–fetal interface: an overview of pathogenesis and defence. Nat Rev Microbiol. 2021;20(2):1-16. doi: 10.1038/s41579-021-00610-y
  25. Kirschen GW, Panda S, Burd I. Congenital Infection Influence on Early Brain Development Through the Gut-Brain Axis. Front Neurosci. 2022;16. doi: 10.3389/fnins.2022.894955
  26. Fortin O, Mulkey SB. Neurodevelopmental outcomes in congenital and perinatal infections. Curr Opin Infect Dis. 2023;36(5):405-413. doi: 10.1097/QCO.0000000000000946
  27. Keymeulen A, De Leenheer E, Casaer A, et al. Neurodevelopmental outcome in children with congenital cytomegalovirus infection: A prospective multicenter cohort study. Early Hum Dev. 2023;182:105777. doi: 10.1016/j.earlhumdev.2023.105777
  28. Morelli S, Mandal M, Goldsmith LT, Kashani BN, Ponzio NM. The maternal immune system during pregnancy and its influence on fetal development. Res Rep Biol. 2015;6:171-189. doi: 10.2147/rrb.s80652
  29. O’Connor TG, Ciesla AA. Maternal Immune Activation Hypotheses for Human Neurodevelopment: Some Outstanding Questions. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022;7(5):471-479. doi: 10.1016/j.bpsc.2021.10.006
  30. Zhang X, Luo W, He K, et al. IL-6 Inhibition Partially Ameliorates Maternal Immune Activation-Induced Autism-Like Behavioral Abnormalities in Mice. Curr Issues Mol Biol. 2025;47(10):852. doi: 10.3390/cimb47100852
  31. Choi GB, Yim YS, Wong H, et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science. 2016;351(6276):933-939. doi: 10.1126/science.aad0314
  32. Baines KJ, Hillier DM, Haddad FL, Rajakumar N, Schmid S, Renaud SJ. Maternal Immune Activation Alters Fetal Brain Development and Enhances Proliferation of Neural Precursor Cells in Rats. Front Immunol. 2020;11:1145. doi: 10.3389/fimmu.2020.01145
  33. Quagliato LA, de Matos U, Nardi AE. Maternal immune activation generates anxiety in offspring: A translational meta-analysis. Transl Psychiatry. 2021;11(1). doi: 10.1038/s41398-021-01361-3
  34. Gall AR, Amoah S, Kitase Y, Jantzie LL. Placental mediated mechanisms of perinatal brain injury: Evolving inflammation and exosomes. Exp Neurol. 2022;347:113914. doi: 10.1016/j.expneurol.2021.113914
  35. Sotiros A, Thornhill D, Post MD, Winn VD, Armstrong J. Inflammatory cytokines, placental pathology, and neurological outcomes in infants born to preterm preeclamptic mothers. PLoS ONE. 2021;16(11):e0260094. doi: 10.1371/journal.pone.0260094
  36. Kwon HK, Choi GB, Huh JR. Maternal inflammation and its ramifications on fetal neurodevelopment. Trends Immunol. 2022;43(3):230-244. doi: 10.1016/j.it.2022.01.007
  37. Gyllenhammer LE, Rasmussen JM, Bertele N, et al. Maternal inflammation during pregnancy and offspring brain development: the role of mitochondria. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022;7(5):498-509. doi: 10.1016/j.bpsc.2021.11.003
  38. Matteoli M, Pozzi D, Fossati M, Menna E. Immune synaptopathies: how maternal immune activation impacts synaptic function during development. EMBO J. 2023;42(13). doi: 10.15252/embj.2023113796
  39. Sal-Sarria S, Conejo NM, González-Pardo H. Maternal immune activation and its multifaceted effects on learning and memory in rodent offspring: A systematic review. Neurosci. Amp Biobehav Rev. 2024;164:105844. doi: 10.1016/j.neubiorev.2024.105844
  40. Basil P, Li Q, Dempster EL, et al. Prenatal maternal immune activation causes epigenetic differences in adolescent mouse brain. Transl Psychiatry. 2014;4(9):e434. doi: 10.1038/tp.2014.80
  41. Bergdolt L, Dunaevsky A. Brain changes in a maternal immune activation model of neurodevelopmental brain disorders. Prog Neurobiol. 2019;175:1-19. doi: 10.1016/j.pneurobio.2018.12.002
  42. McEwan F, Glazier JD, Hager R. The impact of maternal immune activation on embryonic brain development. Front Neurosci. 2023;17:1146710. doi: 10.3389/fnins.2023.1146710
  43. Lai CY, Arzavala J, Pinto-Duarte A, et al. Maternal Immune Activation Disrupts Epigenomic and Functional Maturation of Cortical Excitatory Neurons. Mol Psychiatry. 2026. doi: 10.1038/s41380-026-03856-1
  44. Zhu B, Li G, Saunders JM, et al. Prenatal and postnatal effects of gestational immune activation on synaptic and neurodevelopmental pathways via epigenetic mechanisms. Transl Psychiatry. 2026;16:82. doi: 10.1038/s41398-026-03884-z
  45. Paulesu L, Ietta F, Petraglia F. Feto-maternal biology and ethics of human society. Reprod Biol Endocrinol. 2005;3(1). doi: 10.1186/1477-7827-3-55
  46. Tisato V, D’Aversa E, Salvatori F, et al. Epigenetic mechanisms in maternal-fetal crosstalk: inter- and trans-generational inheritance. Epigenomics. 2025;17(17):1303-1322. doi: 10.1080/17501911.2025.2568369
  47. Tang Q, Wang X, Yang F, et al. Pathophysiological associations between maternal immune activation and neurodevelopmental disorders in offspring: a comprehensive review. Front Endocrinol. 2025;16:1681190. doi: 10.3389/fendo.2025.1681190
  48. Yong Q, Zhao C, Xia L, Zhu T, Xia K. Maternal Immune Activation and Neurodevelopmental Disorders: Integrating Molecular, Cellular and Systems Mechanisms. Neuropsychiatr Dis Treat. 2025;21:2575-2594. doi: 10.2147/ndt.s533813
  49. Hall MB, Willis DE, Rodriguez EL, Schwarz JM. Maternal immune activation as an epidemiological risk factor for neurodevelopmental disorders: Considerations of timing, severity, individual differences, and sex in human and rodent studies. Front Neurosci. 2023;17. doi: 10.3389/fnins.2023.1135559
  50. Menzies FM. The Placenta as an Immunological Environment. Br J Biomed Sci. 2025;82:14910. doi: 10.3389/bjbs.2025.14910
  51. Zhang X, Wei H. Role of Decidual Natural Killer Cells in Human Pregnancy and Related Pregnancy Complications. Front Immunol. 2021;12:728291. doi: 10.3389/fimmu.2021.728291
  52. Ning F, Liu H, Lash GE. The Role of Decidual Macrophages During Normal and Pathological Pregnancy. Am J Reprod Immunol. 2016;75(3):298-309. doi: 10.1111/aji.12477
  53. Vishnyakova P, Poltavets A, Nikitina M, et al. Preeclampsia: inflammatory signature of decidual cells in early manifestation of disease. Placenta. 2021;104:277-283. doi: 10.1016/j.placenta.2021.01.011
  54. Cassol E, Cassetta L, Alfano M, Poli G. Macrophage polarization and HIV-1 infection. J Leukoc Biol. 2009;87(4):599-608. doi: 10.1189/jlb.1009673
  55. Quillay H, El Costa H, Marlin R, et al. Distinct Characteristics of Endometrial and Decidual Macrophages and Regulation of Their Permissivity to HIV-1 Infection by SAMHD1. J Virol. 2015;89(2):1329-1339. doi: 10.1128/jvi.01730-14
  56. Woottum M, Yan S, Sayettat S, et al. Macrophages: Key Cellular Players in HIV Infection and Pathogenesis. Viruses. 2024;16(2):288. doi: 10.3390/v16020288
  57. El Costa H, Quillay H, Marlin R, et al. The local environment orchestrates mucosal decidual macrophage differentiation and substantially inhibits HIV-1 replication. Mucosal Immunol. 2016;9(3):634-646. doi: 10.1038/mi.2015.87
  58. Hosking SL, Moldenhauer LM, Tran HM, et al. Treg cells promote decidual vascular remodeling and modulate uterine NK cells in pregnant mice. JCI Insight. 2024;10(2). doi: 10.1172/jci.insight.169836
  59. Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update. 2009;15(5):517-535. doi: 10.1093/humupd/dmp004
  60. Tilburgs T, Strominger JL. CD8+ Effector T Cells at the Fetal-Maternal Interface, Balancing Fetal Tolerance and Antiviral Immunity. Am J Reprod Immunol. 2013;69(4):395-407. doi: 10.1111/aji.12094
  61. Liu L, Huang X, Xu C, et al. Decidual CD8+T cells exhibit both residency and tolerance signatures modulated by decidual stromal cells. J Transl Med. 2020;18(1). doi: 10.1186/s12967-020-02371-3
  62. van der Zwan A, Bi K, Norwitz ER, et al. Mixed signature of activation and dysfunction allows human decidual CD8+ T cells to provide both tolerance and immunity. Proc Natl Acad Sci. 2017;115(2):385-390. doi: 10.1073/pnas.1713957115
  63. Guo L, Guo A, Guo Y, et al. Enrichment of decidual CD11c + CD8 + T cells with altered immune function in early pregnancy loss. Nat Commun. 2025;16(1):6678-6678. doi: 10.1038/s41467-025-61992-8
  64. Shiau S, Jacobson DL, Huo Y, et al. Unique Profile of Inflammation and Immune Activation in Pregnant People With HIV in the United States. J Infect Dis. 2023;227(5):720-730. doi: 10.1093/infdis/jiac501
  65. Amin O, Powers J, Bricker KM, Chahroudi A. Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure. Front Immunol. 2021;12:757400. doi: 10.3389/fimmu.2021.757400
  66. Johnson EL, Swieboda D, Olivier A, Enninga EAL, Chakraborty R. Robust innate immune responses at the placenta during early gestation may limit in utero HIV transmission. PLoS Pathogens. 2021;17(8):e1009860. doi: 10.1371/journal.ppat.1009860
  67. Lee TH, Chafets DM, Biggar RJ, McCune JM, Busch MP. The Role of Transplacental Microtransfusions of Maternal Lymphocytes in In Utero HIV Transmission. JAIDS J Acquir Immune Defic Syndr. 2010;55(2):143-147. doi: 10.1097/qai.0b013e3181eb301e
  68. Quicke KM, Bowen JR, Johnson EL, et al. Zika Virus Infects Human Placental Macrophages. Cell Host Microbe. 2016;20(1):83-90. doi: 10.1016/j.chom.2016.05.015
  69. Tabata T, Petitt M, Puerta-Guardo H, et al. Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission. Cell Host Microbe. 2016;20(2):155-166. doi: 10.1016/j.chom.2016.07.002
  70. Wong SCS, Fung J, Hau PT, et al. Zika virus and the fetal-maternal interface: deciphering the mechanisms of placental infection and implications for pregnancy outcomes. Emerg Microbes Infect. 2025;14(1). doi: 10.1080/22221751.2025.2532681
  71. Koenig MR, Vazquez J, Leyva Jaimes FB, Mitzey AM, Stanic AK, Golos TG. Decidual leukocytes respond to African lineage Zika virus infection with mild anti-inflammatory changes during acute infection in rhesus macaques. Front Immunol. 2024;15:1363169. doi: 10.3389/fimmu.2024.1363169
  72. Lee LJ, Komarasamy TV, Adnan NAA, James W, Balasubramaniam VRMT. Hide and Seek: The Interplay Between Zika Virus and the Host Immune Response. Front Immunol. 2021;12:750365. doi: 10.3389/fimmu.2021.750365
  73. Sen Santara S, Crespo ÂC, Mulik S, et al. Decidual NK cells kill Zika virus–infected trophoblasts. Proc Natl Acad Sci USA. 2021;118(47). doi: 10.1073/pnas.2115410118
  74. Garcez PP, Loiola EC, Madeiro da Costa R, et al. Zika virus impairs growth in human neurospheres and brain organoids. Science. 2016;352(6287):816-818. doi: 10.1126/science.aaf6116
  75. Li H, Saucedo-Cuevas L, Regla-Nava JA, et al. Zika Virus Infects Neural Progenitors in the Adult Mouse Brain and Alters Proliferation. Cell Stem Cell. 2016;19(5):593-598. doi: 10.1016/j.stem.2016.08.005
  76. Dang J, Tiwari SK, Lichinchi G, et al. Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids through Activation of the Innate Immune Receptor TLR3. Cell Stem Cell. 2016;19(2):258-265. doi: 10.1016/j.stem.2016.04.014
  77. Olagnier D, Muscolini M, Coyne CB, Diamond MS, Hiscott J. Mechanisms of Zika Virus Infection and Neuropathogenesis. DNA Cell Biol. 2016;35(8):367-372. doi: 10.1089/dna.2016.3404
  78. Ferraris P, Cochet M, Hamel R, et al. Zika virus differentially infects human neural progenitor cells according to their state of differentiation and dysregulates neurogenesis through the Notch pathway. Emerg Microbes Infect. 2019;8(1):1003-1016. doi: 10.1080/22221751.2019.1637283
  79. Cheeran MCJ, Lokensgard JR, Schleiss MR. Neuropathogenesis of Congenital Cytomegalovirus Infection: Disease Mechanisms and Prospects for Intervention. Clin Microbiol Rev. 2009;22(1):99-126. doi: 10.1128/CMR.00023-08
  80. Davis NL, King CC, Kourtis AP. Cytomegalovirus infection in pregnancy. Birth Defects Res. 2017;109(5):336-346. doi: 10.1002/bdra.23601
  81. Shimada K, Toriyabe K, Kitamura A, et al. Primary cytomegalovirus infection during pregnancy and congenital infection: a population-based, mother–child, prospective cohort study. J Perinatol. 2021;41(10):2474-2481. doi: 10.1038/s41372-021-01157-9
  82. Pereira L, Petitt M, Tabata T. Cytomegalovirus Infection and Antibody Protection of the Developing Placenta. Clin Infect Dis. 2013;57(suppl 4):S174-S177. doi: 10.1093/cid/cit583
  83. Weisblum Y, Panet A, Zakay-Rones Z, et al. Modeling of Human Cytomegalovirus Maternal-Fetal Transmission in a Novel Decidual Organ Culture. J Virol. 2011;85(24):13204-13213. doi: 10.1128/jvi.05749-11
  84. Fisher S, Genbacev O, Maidji E, Pereira L. Human Cytomegalovirus Infection of Placental Cytotrophoblasts In Vitro and In Utero: Implications for Transmission and Pathogenesis. J Virol. 2000;74(15):6808-6820. doi: 10.1128/jvi.74.15.6808-6820.2000
  85. Poncet D, Anne-Laure Pauleau, Gyorgy Szabadkai, et al. Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA. J Cell Biol. 2006;174(7):985-996. doi: 10.1083/jcb.200604069
  86. Tabata T, Petitt M, Zydek M, et al. Human Cytomegalovirus Infection Interferes with the Maintenance and Differentiation of Trophoblast Progenitor Cells of the Human Placenta. J Virol. 2015;89(9):5134-5147. doi: 10.1128/jvi.03674-14
  87. Pereira L, Tabata T, Petitt M, Fang-Hoover J. Congenital cytomegalovirus infection undermines early development and functions of the human placenta. Placenta. 2017;59:S8-S16. doi: 10.1016/j.placenta.2017.04.020
  88. Hamilton ST, Scott G, Naing Z, et al. Human Cytomegalovirus-Induces Cytokine Changes in the Placenta with Implications for Adverse Pregnancy Outcomes. PLoS ONE. 2012;7(12):e52899. doi: 10.1371/journal.pone.0052899
  89. Rovito R, Claas FHJ, Haasnoot GW, et al. Congenital Cytomegalovirus Infection: Maternal–Child HLA-C, HLA-E, and HLA-G Affect Clinical Outcome. Front Immunol. 2018;8. doi: 10.3389/fimmu.2017.01904
  90. Siewiera J, El Costa H, Tabiasco J, et al. Human Cytomegalovirus Infection Elicits New Decidual Natural Killer Cell Effector Functions. PLoS Pathogens. 2013;9(4):e1003257. doi: 10.1371/journal.ppat.1003257
  91. Kirschen GW, Burd I. Modeling of vertical transmission and pathogenesis of cytomegalovirus in pregnancy: Opportunities and challenges. Front Virol. 2023;3:1106634. doi: 10.3389/fviro.2023.1106634
  92. Scott GM, Chow SSW, Craig ME, et al. Cytomegalovirus Infection During Pregnancy With Maternofetal Transmission Induces a Proinflammatory Cytokine Bias in Placenta and Amniotic Fluid. J Infect Dis. 2012;205(8):1305-1310. doi: 10.1093/infdis/jis186
  93. Negi VD, Khurana S, Bonney EA. Interleukin-10 Delays Viral Clearance in the Placenta and Uterus of Mice With Acute Lymphocytic Choriomeningitis Virus Infection During Pregnancy. Front Virol. 2022;2. doi: 10.3389/fviro.2022.829991
  94. Kawasaki H, Kosugi I, Meguro S, Iwashita T. Pathogenesis of developmental anomalies of the central nervous system induced by congenital cytomegalovirus infection. Pathol Int. 2017;67(2):72-82. doi: 10.1111/pin.12502
  95. Gabrielli L, Bonasoni MP, Santini D, et al. Congenital cytomegalovirus infection: patterns of fetal brain damage. Clin Microbiol Infect. 2012;18(10):E419-E427. doi: 10.1111/j.1469-0691.2012.03983.x
  96. Wedderburn CJ, Evans C, Yeung S, Gibb DM, Donald KA, Prendergast AJ. Growth and Neurodevelopment of HIV-Exposed Uninfected Children: a Conceptual Framework. Current HIV/AIDS Rep. 2019;16(6):501-513. doi: 10.1007/s11904-019-00459-0
  97. Slogrove AL, Tamlyn S, Kalk E, et al. Survival and health of children who are HIV-exposed uninfected: study protocol for the CHERISH (Children HIV-Exposed Uninfected - Research to Inform Survival and Health) dynamic, prospective, maternal-child cohort study. BMJ Open. 2023;13(1):e070465. doi: 10.1136/bmjopen-2022-070465
  98. Cachay R, Schwalb A, Watanabe T, et al. Case Report: Multiorgan Involvement with Congenital Zika Syndrome. Am J Trop Med Hyg. 2020;103(4):1656-1659. doi: 10.4269/ajtmh.20-0421
  99. de Lima Nascimento Coutinho DL, Feldner H, Coelho MLG, Monteiro KS, Longo E. The burden of global outbreaks: Photos of the daily lives of children with congenital Zika syndrome during the COVID‐19 pandemic. Health Expect. 2023;26(6):2500-2513. doi: 10.1111/hex.13717
  100. Benazzato C, Lojudice F, Pöehlchen F, et al. Zika virus vertical transmission induces neuroinflammation and synapse impairment in brain cells derived from children born with Congenital Zika Syndrome. Sci Rep. 2024;14(1):18002. doi: 10.1038/s41598-024-65392-8
  101. Salomè S, Corrado FR, Mazzarelli LL, et al. Congenital cytomegalovirus infection: the state of the art and future perspectives. Front Pediatrics. 2023;11:1276912. doi: 10.3389/fped.2023.1276912
  102. Phillips N, Amos T, Kuo C, et al. HIV-Associated Cognitive Impairment in Perinatally Infected Children: A Meta-analysis. Pediatrics. 2016;138(5). doi: 10.1542/peds.2016-0893
  103. Marques FJP, Tran L, Kousa YA, Leyser M. Long-term developmental outcomes of children with congenital Zika syndrome. Pediatr Res. 2024;97(3):989-993. doi: 10.1038/s41390-024-03389-9
  104. Amaral YN di V, Malacarne J, Brandão PG, Brasil P, Nielsen-Saines K, Moreira MEL. Time to Evaluate the Clinical Repercussions of Zika Virus Vertical Transmission? A Systematic Review. Front Psychiatry. 2021;12. doi: 10.3389/fpsyt.2021.699115
  105. Boppana SB, Ross SA, Fowler KB. Congenital Cytomegalovirus Infection: Clinical Outcome. Clin Infect Dis. 2013;57(suppl 4):S178-S181. doi: 10.1093/cid/cit629
  106. Townsend CL, Forsgren M, Ahlfors K, Ivarsson SA, Tookey PA, Peckham CS. Long-term Outcomes of Congenital Cytomegalovirus Infection in Sweden and the United Kingdom. Clin Infect Dis. 2013;56(9):1232-1239. doi: 10.1093/cid/cit018
  107. Lanzieri TM, Leung J, Caviness AC, et al. Long-term outcomes of children with symptomatic congenital cytomegalovirus disease. J Perinatol. 2017;37(7):875-880. doi: 10.1038/jp.2017.41
  108. Mpango RS, Kinyanda E, Rukundo GZ, Levin J, Gadow KD, Patel V. Prevalence and correlates for ADHD and relation with social and academic functioning among children and adolescents with HIV/AIDS in Uganda. BMC Psychiatry. 2017;17(1). doi: 10.1186/s12888-017-1488-7
  109. Boivin MJ, Barlow-Mosha L, Chernoff MC, et al. Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial. AIDS. 2018;32(2):189-204. doi: 10.1097/qad.0000000000001683
  110. Crowell CS, Williams PL, Yildirim C, et al. Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected. AIDS. 2020;34(9):1377-1387. doi: 10.1097/qad.0000000000002550
  111. Bulterys MA, Njuguna I, Mahy M, et al. Neurodevelopment among children exposed to HIV and uninfected in sub‐Saharan Africa. J Int AIDS Soc. 2023;26:1-8. doi: 10.1002/jia2.26159
  112. Mulkey SB, Arroyave-Wessel M, Peyton C, et al. Neurodevelopmental Abnormalities in Children With In Utero Zika Virus Exposure Without Congenital Zika Syndrome. JAMA Pediatrics. 2020;174(3):269. doi: 10.1001/jamapediatrics.2019.5204
  113. Wheeler AC, Toth D, Ridenour T, et al. Developmental Outcomes Among Young Children With Congenital Zika Syndrome in Brazil. JAMA Netw Open. 2020;3(5):e204096. doi: 10.1001/jamanetworkopen.2020.4096
  114. Antoniou E, Orovou E, Andronikidi PE, et al. Congenital Zika Infection and the Risk of Neurodevelopmental, Neurological, and Urinary Track Disorders in Early Childhood. A Systematic Review. Viruses. 2021;13(8):1671. doi: 10.3390/v13081671
  115. Jenco M. Study: Congenital cytomegalovirus infection linked to autism. American Academy of Pediatrics; 2024. Accessed September 10, 2026. https://publications.aap.org/aapnews/news/29088/Study-Congenital-cytomegalovirus-infection-linked?autologincheck=redirected
  116. Pesch MH, Leung J, Lanzieri TM, et al. Autism Spectrum Disorder Diagnoses and Congenital Cytomegalovirus. Pediatrics. 2024;153(6). doi: 10.1542/peds.2023-064081
  117. Korndewal MJ, Oudesluys-Murphy AM, Kroes ACM, van der Sande MAB, de Melker HE, Vossen ACTM. Long-term impairment attributable to congenital cytomegalovirus infection: a retrospective cohort study. Dev Med Child Neurol. 2017;59(12):1261-1268. doi: 10.1111/dmcn.13556
  118. Epstein LG, Sharer LR, Goudsmit J. Neurological and neuropathological features of human immunodeficiency virus infection in children. Ann Neurol. 1988;23(suppl 1):S19-S23. doi: 10.1002/ana.410230709
  119. Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR. Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS. 2009;23(14):1893-1901. doi: 10.1097/QAD.0b013e32832dc041
  120. Wachsler-Felder JL, Golden CJ. Neuropsychological consequences of HIV in children. Clinical Psychology Review. 2002;22(3):441-462. doi: 10.1016/s0272-7358(01)00108-8
  121. Van Rie A, Harrington PR, Dow A, Robertson K. Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: A global perspective. Eur J Paediatr Neurol. 2007;11(1):1-9. doi: 10.1016/j.ejpn.2006.10.006
  122. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355-363. doi: 10.1002/rmv.544
  123. Smyrli A, Raveendran V, Walter S, et al. What are the neurodevelopmental outcomes of children with asymptomatic congenital cytomegalovirus infection at birth? A systematic literature review. Rev Med Virol. 2024;34(4):e2555. doi: 10.1002/rmv.2555
  124. Too EK, Abubakar A, Nasambu C, et al. Prevalence and factors associated with common mental disorders in young people living with HIV in sub‐Saharan Africa: a systematic review. J Int AIDS Soc. 2021;24(suppl 2):e25705. doi: 10.1002/jia2.25705
  125. Olashore AA, Paruk S, Akanni OO, Chiliza B. Psychiatric disorders in adolescents living with HIV in Botswana. AIDS Res Ther. 2023;20(1). doi: 10.1186/s12981-022-00490-z
  126. Singer EJ, Thames AD. Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS. Neurol Clin. 2016;34(1):33-53. doi: 10.1016/j.ncl.2015.08.003
  127. Mallik I, Pasvol T, Frize G, et al. Psychotic disorders in young adults with perinatally acquired HIV: a UK case series. Psychol Med. 2020;52(12):2263-2269. doi: 10.1017/s0033291720004134
  128. Mellins CA, Malee KM. Understanding the mental health of youth living with perinatal HIV infection: lessons learned and current challenges. J Int AIDS Soc. 2013;16(1). doi: 10.7448/ias.16.1.18593
  129. Bucek A, Mellins CA, Leu CS, et al. Psychiatric disorders and young adult milestones in HIV-exposed, uninfected youth. AIDS Care. 2020;32(4):420-428. doi: 10.1080/09540121.2019.1668535
  130. Chaudhury S, Williams PL, Mayondi GK, et al. Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months. Pediatrics. 2017;140(4). doi: 10.1542/peds.2017-0988
  131. Blomström Å, Karlsson H, Wicks S, Yang S, Yolken RH, Dalman C. Maternal antibodies to infectious agents and risk for non-affective psychoses in the offspring—a matched case–control study. Schizophr Res. 2012;140(1-3):25-30. doi: 10.1016/j.schres.2012.06.035
  132. Børglum AD, Demontis D, Grove J, et al. Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci. Mol Psychiatry. 2013;19(3):325-333. doi: 10.1038/mp.2013.2
  133. Brown AS, Patterson PH. Maternal Infection and Schizophrenia: Implications for Prevention. Schizophr Bull. 2010;37(2):284-290. doi: 10.1093/schbul/sbq146
  134. Shiau S, Strehlau R, Wang S, et al. Distinct epigenetic profiles in children with perinatally-acquired HIV on antiretroviral therapy. Sci Rep. 2019;9(1):10495. doi: 10.1038/s41598-019-46930-1
  135. Oldenburg KS, O’Shea TM, Fry RC. Genetic and epigenetic factors and early life inflammation as predictors of neurodevelopmental outcomes. Semin Fetal Neonatal Med. 2020;25(3):101115. doi: 10.1016/j.siny.2020.101115
  136. Han VX, Patel S, Jones HF, Dale RC. Maternal immune activation and neuroinflammation in human neurodevelopmental disorders. Nat Rev Neurol. 2021;17(9):564-579. doi: 10.1038/s41582-021-00530-8
  137. Yi L, Pimentel H, Pachter L. Zika infection of neural progenitor cells perturbs transcription in neurodevelopmental pathways. PLoS ONE. 2017;12(4):e0175744. doi: 10.1371/journal.pone.0175744
  138. Jiang X, Liu S, Fu YR, et al. Human cytomegalovirus infection perturbs neural progenitor cell fate via the expression of viral microRNAs. J Med Virol. 2023;95(2). doi: 10.1002/jmv.28574
  139. Goulding AN, Meeks K, Shay L, Casey S, Applegarth C, McKinney J. Antiretroviral Therapy in Pregnancy: A 2023 Review of the Literature. Curr HIV/AIDS Rep. 2024;21(1):1-10. doi: 10.1007/s11904-024-00688-y
  140. Ekali GL, Enok R, Kengne-Nde C, et al. Growth of children who are HIV-exposed but uninfected: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2025;9(4):234-247. doi: 10.1016/s2352-4642(25)00027-6
  141. Mulkey SB, Williams ME, Peyton C, et al. Understanding the multidimensional neurodevelopmental outcomes in children after congenital Zika virus exposure. Pediatr Res. 2024;96(3):654-662. doi: 10.1038/s41390-024-03056-z
  142. Freitas DA, Souza-Santos R, Carvalho LMA, et al. Congenital Zika syndrome: A systematic review. PLoS ONE. 2020;15(12):e0242367. doi: 10.1371/journal.pone.0242367
  143. Faiçal AV, de Oliveira JC, Oliveira JVV, et al. Neurodevelopmental delay in normocephalic children with in utero exposure to Zika virus. BMJ Paediatr Open. 2019;3(1):e000486. doi: 10.1136/bmjpo-2019-000486
  144. Lanari M, Capretti MG, Lazzarotto T, et al. Neuroimaging in CMV congenital infected neonates: how and when. Early Hum Dev. 2012;88:S3-S5. doi: 10.1016/s0378-3782(12)70003-8
  145. Hranilovich JA, Park AH, Knackstedt ED, et al. Brain Magnetic Resonance Imaging in Congenital Cytomegalovirus With Failed Newborn Hearing Screen. Pediatric Neurol. 2020;110:55-58. doi: 10.1016/j.pediatrneurol.2020.05.006
  146. Oliver SE, Cloud GA, Sánchez PJ, et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009;46:S22-S26. doi: 10.1016/j.jcv.2009.08.012
  147. Sevenoaks T, Wedderburn CJ, Donald KA, et al. Association of maternal and infant inflammation with neurodevelopment in HIV-exposed uninfected children in a South African birth cohort. Brain Behav Immun. 2021;91:65-73. doi: 10.1016/j.bbi.2020.08.021
  148. Suleri A, Rommel AS, Dmitrichenko O, et al. The association between maternal immune activation and brain structure and function in human offspring: a systematic review. Mol Psychiatry. 2024;30(2):722-735. doi: 10.1038/s41380-024-02760-w
  149. Weber-Stadlbauer U. Epigenetic and transgenerational mechanisms in infection-mediated neurodevelopmental disorders. Transl Psychiatry 2017;7(5):e1113-e1113. doi: 10.1038/tp.2017.78
  150. Yan S, Wang Y, Chen Z, Zhang F. Chorionicity and neurodevelopmental outcomes in twin pregnancy: a systematic review and meta-analysis. J Perinatol. 2022;43(2):133-146. doi: 10.1038/s41372-022-01534-y
  151. Chen Q, Shan D, Xie Y, et al. Single cell RNA sequencing research in maternal fetal interface. Front Cell Dev Biol. 2023;10. doi: 10.3389/fcell.2022.1079961
  152. Nguyen PN, Vuong ADB, Pham XTT. Neonatal outcomes in the surgical management of placenta accreta spectrum disorders: a retrospective single-center observational study from 468 Vietnamese pregnancies beyond 28 weeks of gestation. BMC Pregnancy Childbirth. 2024;24(1). doi: 10.1186/s12884-024-06349-7
  153. Rahnavard A, Chatterjee R, Wen H, et al. Molecular epidemiology of pregnancy using omics data: advances, success stories, and challenges. J Transl Med. 2024;22(1). doi: 10.1186/s12967-024-04876-7
Next article in this issue
Share
Back to top
Journal of Clinical and Translational Research, Electronic ISSN: 2424-810X Print ISSN: 2382-6533, Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept